2023-02-23 10:03
Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901
On 23 February, 2023, Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed Biosciences Inc., (“Keymed”) (Stock Code: 02162 HK) today jointly announces a global exclusive licence...
More